Rankings · Growth
Free cash flow growing fastest
Graded A or B, with at least $250M of free cash flow now and $100M three years ago, ranked by its yearly growth over those three years. Banks, insurers and brokers are left out: their cash flow moves with customers’ money.
62 companies meet this test
Figures as of November 15, 2026
| # | Company | Grade | Free cash flow growth | Revenue growth | Free cash flow yield | Market value |
|---|---|---|---|---|---|---|
| 1 | SNNSmith & Nephew plc | B | +98% a year | +6% a year | 6.2% | $13.7B |
| 2 | ILMNIllumina, Inc. | A+ | +84% a year | +1% a year | 3.4% | $31.3B |
| 3 | GMEDGLOBUS MEDICAL, INC. | B+ | +81% a year | +37% a year | 7.9% | $9.7B |
| 4 | LLYELI LILLY AND COMPANY | A+ | +81% a year | +39% a year | 1.4% | $1.36T |
| 5 | BTSGBrightSpring Health Services, Inc. | A | +53% a year | +26% a year | 3.5% | $14.2B |
| 6 | EXELEXELIXIS, INC. | A+ | +48% a year | +12% a year | 6.9% | $16.8B |
| 7 | COOThe Cooper Companies, Inc. | B | +45% a year | +6% a year | 5.7% | $11.9B |
| 8 | ALCAlcon Inc. | A | +44% a year | +5% a year | 4.8% | $36.1B |
| 9 | THCTENET HEALTHCARE CORP | A+ | +43% a year | +3% a year | 14.6% | $22.8B |
| 10 | ISRGIntuitive Surgical, Inc. | A+ | +42% a year | +19% a year | 2.3% | $153.8B |
| 11 | UHSUNIVERSAL HEALTH SERVICES, INC. | B | +39% a year | +9% a year | 9.7% | $11.5B |
| 12 | NBIXNEUROCRINE BIOSCIENCES, INC. | A+ | +39% a year | +28% a year | 6.1% | $16.9B |
| 13 | HALOHALOZYME THERAPEUTICS, INC. | A+ | +36% a year | +32% a year | 7.7% | $11.4B |
| 14 | HRMYHARMONY BIOSCIENCES HOLDINGS, INC. | B+ | +34% a year | +22% a year | 17.5% | $2B |
| 15 | HQYHEALTHEQUITY, INC. | A+ | +32% a year | +13% a year | 5.7% | $8.6B |
| 16 | DGXQuest Diagnostics Inc | A | +32% a year | +8% a year | 4.8% | $28.6B |
| 17 | HAEHAEMONETICS CORPORATION | A | +30% a year | +4% a year | 5.3% | $5.6B |
| 18 | DXCMDEXCOM, INC. | B+ | +30% a year | +14% a year | 3.5% | $31.1B |
| 19 | BHCBausch Health Companies Inc. | A | +26% a year | +9% a year | 59.7% | $3.1B |
| 20 | RMDResMed Inc. | B+ | +25% a year | +9% a year | 4.8% | $33.7B |
| 21 | BIIBBIOGEN INC. | A | +25% a year | +1% a year | 5.5% | $37.5B |
| 22 | IDXXIDEXX LABORATORIES INC /DE | A+ | +24% a year | +9% a year | 2.4% | $55.5B |
| 23 | CAHCardinal Health, Inc. | B | +24% a year | +7% a year | 7.0% | $65B |
| 24 | DOCSDoximity, Inc. | B+ | +22% a year | +14% a year | 5.5% | $5.9B |
| 25 | SYKSTRYKER CORP | A+ | +21% a year | +10% a year | 3.9% | $117.9B |
More rankings
A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.